(Q44129220)

English

A phase II study of the MDR inhibitor biricodar (INCEL, VX-710) and paclitaxel in women with advanced ovarian cancer refractory to paclitaxel therapy

scientific article published in September 2002

Statements

A phase II study of the MDR inhibitor biricodar (INCEL, VX-710) and paclitaxel in women with advanced ovarian cancer refractory to paclitaxel therapy (English)
Michael V Seiden
Kenneth D Swenerton
Susan Campos
Peter Rose
Gerald Batist
Ene Ette
Varun Garg
Arlan Fuller
Matthew W Harding
Danielle Charpentier
1 September 2002
302-310

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit